Clinical Trials
3 trialsNCT06533657 2026-04-21
UTOPIA-1
ZYUS Life Sciences Inc.
Phase 2 Completed
NCT03948074 2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2 Completed
NCT00316563 2010-02-09
Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
AHS Cancer Control Alberta
Phase 2 Completed